ABO and Glucose intolerance: Finally, inhibition of brain STAT3 signaling by i.c.v. treatment with AG490 normalized peripheral glucose tolerance in AβO-infused mice (Fig. 5f), and i.c.v. treatment with anti-IL-6 reversed glucose intolerance in APP/PS1 mice (Fig. 5g).